Incidental Adrenal Nodules in Patients Without Known Malignancy: Prevalence of Malignancy and Utility of Washout CT for Characterization-A Multiinstitutional Study
- PMID: 35731098
- DOI: 10.2214/AJR.22.27901
Incidental Adrenal Nodules in Patients Without Known Malignancy: Prevalence of Malignancy and Utility of Washout CT for Characterization-A Multiinstitutional Study
Abstract
BACKGROUND. Washout CT is commonly used to evaluate indeterminate adrenal nodules, although its diagnostic performance is poorly established in true adrenal incidentalomas. OBJECTIVE. The purpose of this study was to compare, in patients without a known malignancy history, the prevalence of malignancy for incidental adrenal nodules with unenhanced attenuation more than 10 HU that do and do not show absolute washout of 60% or more, thereby determining the diagnostic performance of washout CT for differentiating benign from malignant incidental adrenal nodules. METHODS. This retrospective six-institution study included 299 patients (mean age, 57.3 years; 180 women, 119 men) without known malignancy or suspicion for functioning adrenal tumor who underwent washout CT, which showed a total of 336 adrenal nodules with a short-axis diameter of 1 cm or more, homogeneity, and unenhanced attenuation over 10 HU. The date of the first CT ranged across institutions from November 1, 2003, to January 1, 2017. Washout was determined for all nodules. Reference standard was pathology (n = 54), imaging follow-up (≥ 1 year) (n = 269), or clinical follow-up (≥ 5 years) (n = 13). RESULTS. Prevalence of malignancy among all nodules, nodules less than 4 cm, and nodules 4 cm or more was 1.5% (5/336; 95% CI, 0.5-3.4%), 0.3% (1/317; 95% CI, 0.0-1.7%), and 21.1% (4/19; 95% CI, 6.1-45.6%), respectively. Prevalence of malignancy was not significantly different for nodules smaller than 4 cm with (0% [0/241]; 95% CI, 0.0-1.2%) and without (1.3% [1/76]; 95% CI, 0.0-7.1%) washout of 60% or more (p = .08) or for nodules 4 cm or larger with (16.7% [1/6]; 95% CI, 0.4-64.1%) and without (23.1% [3/13]; 95% CI, 5.0-53.8%) washout of 60% or more (p = .75). Washout of 60% or more was observed in 75.5% (243/322; 95% CI, 70.4-80.1%) of benign nodules (excluding pheochromocytomas), 20.0% (1/5; 95% CI, 0.5-71.6%) of malignant nodules, and 33.3% (3/9; 95% CI, 7.5-70.1%) of pheochromocytomas. For differentiating benign nodules from malignant nodules and pheochromocytomas, washout of 60% or more had 77.5% sensitivity, 70.0% specificity, 98.8% PPV, and 9.2% NPV among nodules smaller than 4 cm. CONCLUSION. Prevalence of malignancy is low among incidental homogeneous adrenal nodules smaller than 4 cm with unenhanced attenuation more than 10 HU and does not significantly differ between those with and without washout of 60% or more; wash-out of 60% or more has suboptimal performance for characterizing nodules as benign. CLINICAL IMPACT. Washout CT has limited utility in evaluating incidental adrenal nodules in patients without known malignancy.
Keywords: CT; adrenal; incidentaloma; nodule; washout.
Comment in
-
Editorial Comment: Does Washout CT Still Have a Role for Characterization of Adrenal Incidentalomas?AJR Am J Roentgenol. 2022 Nov;219(5):813. doi: 10.2214/AJR.22.28144. Epub 2022 Jun 29. AJR Am J Roentgenol. 2022. PMID: 35766534 No abstract available.
Similar articles
-
Adrenal washout CT in patients with no history of cancer: a waste of time?Abdom Radiol (NY). 2024 Sep;49(9):3117-3126. doi: 10.1007/s00261-024-04333-5. Epub 2024 May 21. Abdom Radiol (NY). 2024. PMID: 38772953 Free PMC article.
-
Performance of CT With Adrenal-Washout Protocol in Heterogeneous Adrenal Nodules: A Multiinstitutional Study.AJR Am J Roentgenol. 2024 May;222(5):e2330769. doi: 10.2214/AJR.23.30769. Epub 2024 May 29. AJR Am J Roentgenol. 2024. PMID: 38415578
-
Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?AJR Am J Roentgenol. 2013 Jul;201(1):122-7. doi: 10.2214/AJR.12.9620. AJR Am J Roentgenol. 2013. PMID: 23789665
-
Contemporary imaging of incidentally discovered adrenal masses.Biomed Pharmacother. 2017 Mar;87:256-262. doi: 10.1016/j.biopha.2016.12.090. Epub 2017 Jan 4. Biomed Pharmacother. 2017. PMID: 28063406 Review.
-
Diagnostic Accuracy of Computed Tomography to Exclude Pheochromocytoma: A Systematic Review, Meta-analysis, and Cost Analysis.Mayo Clin Proc. 2019 Oct;94(10):2040-2052. doi: 10.1016/j.mayocp.2019.03.030. Epub 2019 Sep 9. Mayo Clin Proc. 2019. PMID: 31515105
Cited by
-
Can MDCT Enhancement Patterns Be Helpful in Differentiating Secretory from Non-Functional Adrenal Adenoma?Medicina (Kaunas). 2023 Dec 29;60(1):72. doi: 10.3390/medicina60010072. Medicina (Kaunas). 2023. PMID: 38256333 Free PMC article.
-
Adrenal washout CT in patients with no history of cancer: a waste of time?Abdom Radiol (NY). 2024 Sep;49(9):3117-3126. doi: 10.1007/s00261-024-04333-5. Epub 2024 May 21. Abdom Radiol (NY). 2024. PMID: 38772953 Free PMC article.
-
Quantitative imaging biomarkers in the assessment of adrenal nodules.Abdom Radiol (NY). 2025 May;50(5):2169-2180. doi: 10.1007/s00261-024-04671-4. Epub 2024 Nov 13. Abdom Radiol (NY). 2025. PMID: 39532734 Review.
-
Combined [18F]Fluorodeoxyglucose PET and [123I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIAN.EBioMedicine. 2025 Jun;116:105735. doi: 10.1016/j.ebiom.2025.105735. Epub 2025 May 20. EBioMedicine. 2025. PMID: 40398350 Free PMC article.
-
Adrenocortical carcinoma classified as benign: the limitations of washout values.Endocrinol Diabetes Metab Case Rep. 2025 Apr 24;2025(2):e240022. doi: 10.1530/EDM-24-0022. Print 2025 Apr 1. Endocrinol Diabetes Metab Case Rep. 2025. PMID: 40273001 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical